Effect of sub-chronic treatment with duloxetine on serotonin-2A receptor function in vivo and in vitro

A. Kagaya, H. Katagiri, Y. Tawara, A. Kugaya, M. Inagaki, I. Miyoshi, H. Jitsuiki, T. Kozuru, S. Kouhata, Y. Uchitomi, S. Morinobu, S. Yamawaki

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

We have investigated the effect of sub-chronic treatment with duloxetine on serotonin (5-HT)-2A receptor in rat brain and the receptor-mediated wet dog shake (WDS). The frequency of WDS, which is mediated by 5-HT-2A receptor stimulation, was significantly lower in rats treated with 20 mg/kg duloxetine for 7 days without the change in the density of 5-HT-2A receptor. The body weight increase was also lower in rats treated with 20 mg/kg duloxetine. Further, we have studied the effect of duloxetine on the receptor-mediated intracellular calcium (Ca2+) signaling using cultured rat glioma cells. In the study of cultured cells, pretreatment with duloxetine for 4 hr potently attenuated the subsequent Ca2+ increase in response to 5-HT without any direct antagonism against 5-HT-2A receptor. These results suggest that duloxetine may change the function of intracellular component distal from 5-HT-2A receptor, resulting in an inhibition of the subsequent Ca2+ rise in response to 5-HT and 5-HT-2A receptor-mediated behavior. These findings suggest the important role of 5-HT-2A receptor for the pathophysiology and treatment of mood disorders.

Original languageEnglish
Pages (from-to)541-554
Number of pages14
JournalBiogenic Amines
Volume16
Issue number6
Publication statusPublished - 2001
Externally publishedYes

Fingerprint

Receptor, Serotonin, 5-HT2A
Serotonin
Dogs
Calcium Signaling
In Vitro Techniques
Duloxetine Hydrochloride
Mood Disorders
Glioma
Cultured Cells
Body Weight
Brain

Keywords

  • C6 glioma cells
  • Calcium
  • Duloxetine
  • Serotonin-2A receptor
  • Wet dog shake

ASJC Scopus subject areas

  • Neuroscience(all)
  • Pharmacology

Cite this

Kagaya, A., Katagiri, H., Tawara, Y., Kugaya, A., Inagaki, M., Miyoshi, I., ... Yamawaki, S. (2001). Effect of sub-chronic treatment with duloxetine on serotonin-2A receptor function in vivo and in vitro. Biogenic Amines, 16(6), 541-554.

Effect of sub-chronic treatment with duloxetine on serotonin-2A receptor function in vivo and in vitro. / Kagaya, A.; Katagiri, H.; Tawara, Y.; Kugaya, A.; Inagaki, M.; Miyoshi, I.; Jitsuiki, H.; Kozuru, T.; Kouhata, S.; Uchitomi, Y.; Morinobu, S.; Yamawaki, S.

In: Biogenic Amines, Vol. 16, No. 6, 2001, p. 541-554.

Research output: Contribution to journalArticle

Kagaya, A, Katagiri, H, Tawara, Y, Kugaya, A, Inagaki, M, Miyoshi, I, Jitsuiki, H, Kozuru, T, Kouhata, S, Uchitomi, Y, Morinobu, S & Yamawaki, S 2001, 'Effect of sub-chronic treatment with duloxetine on serotonin-2A receptor function in vivo and in vitro', Biogenic Amines, vol. 16, no. 6, pp. 541-554.
Kagaya A, Katagiri H, Tawara Y, Kugaya A, Inagaki M, Miyoshi I et al. Effect of sub-chronic treatment with duloxetine on serotonin-2A receptor function in vivo and in vitro. Biogenic Amines. 2001;16(6):541-554.
Kagaya, A. ; Katagiri, H. ; Tawara, Y. ; Kugaya, A. ; Inagaki, M. ; Miyoshi, I. ; Jitsuiki, H. ; Kozuru, T. ; Kouhata, S. ; Uchitomi, Y. ; Morinobu, S. ; Yamawaki, S. / Effect of sub-chronic treatment with duloxetine on serotonin-2A receptor function in vivo and in vitro. In: Biogenic Amines. 2001 ; Vol. 16, No. 6. pp. 541-554.
@article{2643f9bb138c449f9d71605949879e85,
title = "Effect of sub-chronic treatment with duloxetine on serotonin-2A receptor function in vivo and in vitro",
abstract = "We have investigated the effect of sub-chronic treatment with duloxetine on serotonin (5-HT)-2A receptor in rat brain and the receptor-mediated wet dog shake (WDS). The frequency of WDS, which is mediated by 5-HT-2A receptor stimulation, was significantly lower in rats treated with 20 mg/kg duloxetine for 7 days without the change in the density of 5-HT-2A receptor. The body weight increase was also lower in rats treated with 20 mg/kg duloxetine. Further, we have studied the effect of duloxetine on the receptor-mediated intracellular calcium (Ca2+) signaling using cultured rat glioma cells. In the study of cultured cells, pretreatment with duloxetine for 4 hr potently attenuated the subsequent Ca2+ increase in response to 5-HT without any direct antagonism against 5-HT-2A receptor. These results suggest that duloxetine may change the function of intracellular component distal from 5-HT-2A receptor, resulting in an inhibition of the subsequent Ca2+ rise in response to 5-HT and 5-HT-2A receptor-mediated behavior. These findings suggest the important role of 5-HT-2A receptor for the pathophysiology and treatment of mood disorders.",
keywords = "C6 glioma cells, Calcium, Duloxetine, Serotonin-2A receptor, Wet dog shake",
author = "A. Kagaya and H. Katagiri and Y. Tawara and A. Kugaya and M. Inagaki and I. Miyoshi and H. Jitsuiki and T. Kozuru and S. Kouhata and Y. Uchitomi and S. Morinobu and S. Yamawaki",
year = "2001",
language = "English",
volume = "16",
pages = "541--554",
journal = "Biogenic Amines",
issn = "0168-8561",
publisher = "Society of Integrated Sciences",
number = "6",

}

TY - JOUR

T1 - Effect of sub-chronic treatment with duloxetine on serotonin-2A receptor function in vivo and in vitro

AU - Kagaya, A.

AU - Katagiri, H.

AU - Tawara, Y.

AU - Kugaya, A.

AU - Inagaki, M.

AU - Miyoshi, I.

AU - Jitsuiki, H.

AU - Kozuru, T.

AU - Kouhata, S.

AU - Uchitomi, Y.

AU - Morinobu, S.

AU - Yamawaki, S.

PY - 2001

Y1 - 2001

N2 - We have investigated the effect of sub-chronic treatment with duloxetine on serotonin (5-HT)-2A receptor in rat brain and the receptor-mediated wet dog shake (WDS). The frequency of WDS, which is mediated by 5-HT-2A receptor stimulation, was significantly lower in rats treated with 20 mg/kg duloxetine for 7 days without the change in the density of 5-HT-2A receptor. The body weight increase was also lower in rats treated with 20 mg/kg duloxetine. Further, we have studied the effect of duloxetine on the receptor-mediated intracellular calcium (Ca2+) signaling using cultured rat glioma cells. In the study of cultured cells, pretreatment with duloxetine for 4 hr potently attenuated the subsequent Ca2+ increase in response to 5-HT without any direct antagonism against 5-HT-2A receptor. These results suggest that duloxetine may change the function of intracellular component distal from 5-HT-2A receptor, resulting in an inhibition of the subsequent Ca2+ rise in response to 5-HT and 5-HT-2A receptor-mediated behavior. These findings suggest the important role of 5-HT-2A receptor for the pathophysiology and treatment of mood disorders.

AB - We have investigated the effect of sub-chronic treatment with duloxetine on serotonin (5-HT)-2A receptor in rat brain and the receptor-mediated wet dog shake (WDS). The frequency of WDS, which is mediated by 5-HT-2A receptor stimulation, was significantly lower in rats treated with 20 mg/kg duloxetine for 7 days without the change in the density of 5-HT-2A receptor. The body weight increase was also lower in rats treated with 20 mg/kg duloxetine. Further, we have studied the effect of duloxetine on the receptor-mediated intracellular calcium (Ca2+) signaling using cultured rat glioma cells. In the study of cultured cells, pretreatment with duloxetine for 4 hr potently attenuated the subsequent Ca2+ increase in response to 5-HT without any direct antagonism against 5-HT-2A receptor. These results suggest that duloxetine may change the function of intracellular component distal from 5-HT-2A receptor, resulting in an inhibition of the subsequent Ca2+ rise in response to 5-HT and 5-HT-2A receptor-mediated behavior. These findings suggest the important role of 5-HT-2A receptor for the pathophysiology and treatment of mood disorders.

KW - C6 glioma cells

KW - Calcium

KW - Duloxetine

KW - Serotonin-2A receptor

KW - Wet dog shake

UR - http://www.scopus.com/inward/record.url?scp=0035569008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035569008&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0035569008

VL - 16

SP - 541

EP - 554

JO - Biogenic Amines

JF - Biogenic Amines

SN - 0168-8561

IS - 6

ER -